Having joined Eli Lilly in June 2015, Justin currently serves as Vice President, Drug Delivery Innovation at Lilly’s Cambridge Innovation Center. In his current role, he is tasked to identify and develop distinct and novel product systems for Lilly’s pipeline which cuts across diabetes, oncology, and Alzheimer’s disease. He is also leading efforts to establish a maker culture within Lilly and developing new innovation & external partnership models in order to accelerate drug delivery innovation.
Prior to joining Lilly, Justin spent 8 years at Becton Dickinson (BD) where he served in various roles focused on identifying, developing, and commercializing drug delivery systems for the biotech, vaccine, and pharmaceutical industries. During his time at BD he helped commercialize and launch more than 10 drug delivery systems and led efforts in defining the innovation agenda for BD’s $1bn drug delivery portfolio.